# Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

> **NCT02748772** · PHASE3 · UNKNOWN · sponsor: **The First People's Hospital of Hefei** · enrollment: 148 (estimated)

## Conditions studied

- Colorectal Neoplasms

## Interventions

- **DRUG:** Two Anti-angiogenesis Drugs（Endostar and Thalidomide）
- **DRUG:** Pure chemotherapy（Xelox）

## Key facts

- **NCT ID:** NCT02748772
- **Lead sponsor:** The First People's Hospital of Hefei
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 148 (ESTIMATED)
- **Last updated:** 2016-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02748772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02748772, "Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02748772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*